Mięsak tłuszczakowaty
Diagnostyka i diagnoza

Mięsak tłuszczakowaty (liposarcoma) stanowi około 20% mięsaków tkanek miękkich u dorosłych i wymaga kompleksowej diagnostyki obejmującej badanie kliniczne, obrazowanie (MRI, CT, PET) oraz ocenę histopatologiczną i molekularną. MRI jest badaniem z wyboru, umożliwiającym ocenę charakterystyki guza, jego relacji anatomicznych oraz obecności komponentu nietłuszczowego, co koreluje z agresywnością nowotworu. CT jest niezbędne do wykrywania przerzutów, zwłaszcza do płuc. Biopsja gruboigłowa pod kontrolą obrazowania stanowi podstawę do potwierdzenia diagnozy i określenia podtypu histologicznego, natomiast badania molekularne (IHC, FISH, RT-PCR) pozwalają na identyfikację charakterystycznych zmian genetycznych, takich jak amplifikacja MDM2 i CDK4 w WD-LS/DDLS czy translokacje t(12;16)(q13;p11) w śluzowatym mięsaku tłuszczakowatym (MLS). Nowoczesne metody, jak test NanoString, umożliwiają szybką i precyzyjną diagnostykę z 97,8% zgodnością ze standardami, skracając czas oczekiwania do 36 godzin.

Diagnostyka mięsaka tłuszczakowatego

Mięsak tłuszczakowaty (liposarcoma) to rzadki typ nowotworu wywodzący się z komórek tłuszczowych i stanowiący około 20% wszystkich mięsaków tkanek miękkich u dorosłych. Prawidłowa diagnostyka tego nowotworu jest kluczowa dla skutecznego leczenia i rokowania pacjenta. Diagnoza mięsaka tłuszczakowatego opiera się na kompleksowym podejściu łączącym badanie kliniczne, badania obrazowe oraz ocenę histopatologiczną i molekularną materiału tkankowego.12

Badanie kliniczne

Proces diagnostyczny rozpoczyna się od dokładnego badania klinicznego i wywiadu z pacjentem. Mięsak tłuszczakowaty często objawia się jako bezbolesna, głęboko położona masa, najczęściej zlokalizowana w kończynach (szczególnie udach) lub w jamie brzusznej. Guz zwykle rośnie powoli, a objawy zależą od jego lokalizacji – w tkankach podskórnych i kończynach pacjenci zazwyczaj zgłaszają wyczuwalną masę, natomiast przy lokalizacji wewnątrzbrzusznej lub wewnątrzklatkowej mogą występować jedynie niespecyficzne dolegliwości bólowe.12

W czasie badania fizykalnego lekarz ocenia wielkość, konsystencję i ruchomość guza oraz jego związek z okolicznymi strukturami. Mięsaki tłuszczakowate mogą być miękkie i mięsiste lub twarde w badaniu palpacyjnym, co zależy od podtypu histologicznego.1

Badania obrazowe

Badania obrazowe odgrywają kluczową rolę w diagnostyce mięsaka tłuszczakowatego, pozwalając określić wielkość guza, jego lokalizację oraz stosunek do struktur sąsiadujących, co jest niezbędne do planowania leczenia, w szczególności zabiegu chirurgicznego.1

Rezonans magnetyczny (MRI)

Rezonans magnetyczny jest badaniem z wyboru w diagnostyce mięsaka tłuszczakowatego ze względu na doskonałe obrazowanie tkanek miękkich. W badaniu MRI mięsaki tłuszczakowate zwykle wykazują hiperintensywny sygnał w obrazach T1-zależnych ze względu na obecność tkanki tłuszczowej, która jest hipointensywna w obrazach T2-zależnych. Intensywność sygnału może się jednak różnić w zależności od podtypu histologicznego i proporcji komponentów tłuszczowych i nietłuszczowych.12

Badanie MRI pozwala na ocenę:

  • Charakterystyki guza, co pomaga w różnicowaniu pomiędzy łagodnymi i złośliwymi masami tkanek miękkich1
  • Relacji guza z sąsiadującymi strukturami, w tym z naczyniami krwionośnymi, nerwami i mięśniami1
  • Obecności komponentu nietłuszczowego, co może sugerować wyższy stopień złośliwości nowotworu1
Tomografia komputerowa (CT)

Tomografia komputerowa wykorzystuje promieniowanie rentgenowskie do tworzenia przekrojowych obrazów ciała. Jest szczególnie przydatna w ocenie wielkości, lokalizacji i zaangażowania guza w sąsiednie struktury. CT jest również niezbędna w wykrywaniu przerzutów, szczególnie do płuc, które są częstym miejscem rozsiewu mięsaka tłuszczakowatego.12

Cechy mięsaka tłuszczakowatego w CT, które różnicują go od łagodnego tłuszczaka, obejmują:

  • Niejednorodną densyjność
  • Obecność znacznej ilości tkanki miękkiej w obrębie masy tłuszczowej
  • Słabą definicję granic w stosunku do sąsiednich struktur
  • Dowody infiltracji lub inwazji sąsiednich struktur
  • Obecność zwapnień12
Inne badania obrazowe

W niektórych przypadkach stosowane są również inne techniki obrazowe:

  • Pozytonowa tomografia emisyjna (PET) – wykorzystuje niewielkie ilości materiału radioaktywnego do identyfikacji obszarów o wysokiej aktywności metabolicznej, co może wskazywać na nowotwór. PET jest szczególnie przydatny w ocenie stopnia zaawansowania choroby i wykrywaniu przerzutów.11
  • Ultrasonografia (USG) – może być stosowana jako badanie wstępne lub jako pomoc w nakierowaniu biopsji. W niektórych przypadkach USG może pomóc w różnicowaniu typów mięsaka tłuszczakowatego na podstawie cech stwierdzanych w badaniu sonograficznym.12

Biopsja

Biopsja jest niezbędna do postawienia ostatecznej diagnozy mięsaka tłuszczakowatego. To jedyny sposób, aby jednoznacznie potwierdzić obecność komórek nowotworowych i określić podtyp histologiczny guza.12

Istnieją różne metody biopsji stosowane w diagnostyce mięsaka tłuszczakowatego:

Biopsja gruboigłowa

Biopsja gruboigłowa (core needle biopsy) jest preferowaną metodą uzyskiwania materiału do oceny histologicznej. Jest dokładniejsza w określaniu stopnia złośliwości i podtypu histologicznego niż biopsja cienkoigłowa. Procedura ta może być wykonywana pod kontrolą USG, CT lub MRI, co zapewnia precyzyjne umiejscowienie igły, szczególnie w przypadku głęboko położonych guzów.12

Biopsja chirurgiczna

W przypadku małych, powierzchownych guzów tłuszczowych zalecana jest biopsja wycinająca. W przypadku dużych (>3 cm) i głębokich guzów, diagnoza i leczenie mogą obejmować otwartą biopsję nacinającą, a następnie definitywną resekcję.1

Biopsja otwarta z późniejszą oceną histologiczną i immunohistochemiczną pobranego materiału jest kluczowa dla planowania leczenia. Ze względu na heterogenność guza, zalecana jest resekcja chirurgiczna dla ostatecznej klasyfikacji.12

Ocena histopatologiczna

Ocena histopatologiczna pobranego materiału tkankowego jest kluczowym elementem diagnozy mięsaka tłuszczakowatego. Materiał biopsyjny oceniany jest przez patologów, którzy specjalizują się w analizie krwi i tkanek ciała. Badają oni komórki, aby określić, czy są nowotworowe, a także przeprowadzają dodatkowe testy w celu uzyskania szczegółowych informacji.1

Kluczowym znaleziskiem w diagnostyce mięsaka tłuszczakowatego jest rozpoznanie lipoblastów – komórek zdolnych do produkcji i akumulacji tłuszczu w cytoplazmie.1

Istnieje kilka podtypów mięsaka tłuszczakowatego, które różnią się obrazem histologicznym i rokowaniem:

  • Dobrze zróżnicowany mięsak tłuszczakowaty/atypowy guz tłuszczowy (WD-LS/ALT) – najczęstszy podtyp, stanowiący około 40-50% wszystkich mięsaków tłuszczakowatych12
  • Odróżnicowany mięsak tłuszczakowaty (DDLS) – rozwija się z dobrze zróżnicowanego mięsaka tłuszczakowatego1
  • Śluzowaty mięsak tłuszczakowaty (myxoid liposarcoma) – drugi co do częstości podtyp, najczęściej występujący w kończynach12
  • Pleomorficzny mięsak tłuszczakowaty – rzadki, szybko rosnący guz1

Badania molekularne i genetyczne

Badania molekularne i genetyczne odgrywają coraz większą rolę w diagnostyce mięsaka tłuszczakowatego, umożliwiając dokładne określenie podtypu nowotworu i wspomagając planowanie leczenia.12

Dobrze zróżnicowany i odróżnicowany mięsak tłuszczakowaty charakteryzuje się amplifikacją genów MDM2 i CDK4, co można wykryć za pomocą immunohistochemii (IHC) lub fluorescencyjnej hybrydyzacji in situ (FISH). Obecność tych markerów genetycznych jest pomocna w różnicowaniu złośliwych mięsaków tłuszczakowatych od łagodnych tłuszczaków.12

W przypadku śluzowatego mięsaka tłuszczakowatego charakterystyczna jest translokacja t(12;16)(q13;p11) prowadząca do fuzji genów FUS-DDIT3 lub rzadziej translokacja t(12;22)(q13;q22) z fuzją EWSR1-DDIT3. Wykrycie tych zmian genetycznych za pomocą FISH lub RT-PCR może potwierdzić diagnozę tego podtypu.12

W ostatnich latach opracowano nowe metody diagnostyczne wykorzystujące najnowsze osiągnięcia w technologii RNA i metodach uczenia maszynowego. Na przykład test panelowy bazujący na technologii NanoString pozwala na szybką i dokładną diagnozę najpowszechniejszych typów mięsaka tłuszczakowatego. Test ten umożliwia niezawodne rozróżnienie łagodnych tłuszczaków od mięsaków tłuszczakowatych i może być wykonywany w laboratoriach przy niższych kosztach niż obecne „złote standardy” diagnostyczne.12

Wyniki badań retrospektywnych i prospektywnych z wykorzystaniem testu NanoString wykazały 93% wskaźnik powodzenia technicznego i 97,8% zgodności ze standardowymi testami. Wyniki z testu NanoString były dostępne w ciągu 36 godzin, podczas gdy uzyskanie wyników FISH zajmowało od jednego do dwóch tygodni.12

Różnicowanie z innymi jednostkami chorobowymi

Mięsak tłuszczakowaty musi być różnicowany z innymi chorobami, które powodują bezbolesny, rosnący guz, takimi jak tłuszczak włóknisty, nerwiakowłókniak, dermatofibrosarcoma protuberans czy złośliwy nowotwór osłonek nerwów obwodowych.1

Szczególnie trudne może być różnicowanie dobrze zróżnicowanego mięsaka tłuszczakowatego od łagodnego tłuszczaka. W tym celu opracowano skale punktowe łączące ocenę kliniczną, radiologiczną i histopatologiczną. Na przykład, w jednym z badań opracowano system punktowy oparty na sześciu czynnikach predykcyjnych (lokalizacja guza, głęboka lokalizacja, wielkość, grubość przegród, wzmocnienie przegród lub zmian guzkowych oraz obecność lipoblastów) z całkowitą liczbą 0-16 punktów i wartością odcięcia 9 punktów. System ten wykazał wysoką dokładność diagnostyczną przy czułości 87,6% i swoistości 91,1%.12

Innym narzędziem pomocnym w różnicowaniu jest trójgenowy podpis oparty na genach PNPLA2, LIPE i PLIN1, który identyfikuje odróżnicowany mięsak tłuszczakowaty ze 100% czułością i 90% swoistością, nawet w próbkach z komponentu dobrze zróżnicowanego guzów DDLS.1

Metody diagnostyki śluzowatego mięsaka tłuszczakowatego

Śluzowaty mięsak tłuszczakowaty (myxoid liposarcoma, MLS) jest rzadkim podtypem mięsaka tłuszczakowatego, który stanowi około 30-40% wszystkich przypadków mięsaka tłuszczakowatego. Jest to drugi co do częstości występowania typ tego nowotworu, charakteryzujący się wyjątkową wrażliwością na radioterapię i tendencją do przerzutów pozapłucnych.12

Objawy kliniczne śluzowatego mięsaka tłuszczakowatego

Wielu pacjentów z śluzowatym mięsakiem tłuszczakowatym może nie zdawać sobie sprawy z choroby, ponieważ guz może nie być zauważalny, dopóki nie urośnie do znacznych rozmiarów. Najczęstszym objawem jest widoczny guz pod skórą ramion lub nóg. Jeśli guz nie powoduje bólu, łatwo go przeoczyć.12

Diagnostyka obrazowa śluzowatego mięsaka tłuszczakowatego

W przypadku podejrzenia śluzowatego mięsaka tłuszczakowatego zalecane są badania obrazowe, takie jak CT lub MRI, w celu określenia wielkości, lokalizacji i ewentualnego rozprzestrzeniania się guza do innych obszarów ciała.1

MRI jest szczególnie przydatne w diagnostyce MLS ze względu na charakterystyczne cechy obrazowe tego podtypu. W badaniu śluzowaty mięsak tłuszczakowaty może wykazywać niejednorodny wygląd z komponentami torbielowatymi i litymi.1

Zdjęcia rentgenowskie mają ograniczoną użyteczność i mogą jedynie wykazać niespecyficzne powiększenie tkanek miękkich. Zarówno tomografia komputerowa (CT), jak i rezonans magnetyczny (MRI) są przydatne i zalecane do przedoperacyjnej oceny zmian oraz do obserwacji po leczeniu.1

Biopsja śluzowatego mięsaka tłuszczakowatego

Aby potwierdzić, czy guz jest śluzowatym mięsakiem tłuszczakowatym, konieczna jest biopsja. Procedura ta polega na użyciu igły do pobrania małej próbki tkanki z guza. Próbka jest następnie badana pod mikroskopem w celu identyfikacji rodzaju guza i potwierdzenia diagnozy.1

Badania genetyczne i molekularne śluzowatego mięsaka tłuszczakowatego

Diagnoza śluzowatego mięsaka tłuszczakowatego może być potwierdzona przez wykazanie obecności translokacji DDIT3-FUS za pomocą fluorescencyjnej hybrydyzacji in situ (FISH) lub RT-PCR. Ta charakterystyczna zmiana genetyczna odróżnia MLS od innych typów mięsaków tłuszczakowatych.1

Śluzowaty mięsak tłuszczakowaty może być mylony z mięsakiem Ewinga, chłoniakiem i pleomorficznymi niezróżnicowanymi mięsakami, dlatego dokładna diagnostyka genetyczna jest istotna dla prawidłowego rozpoznania.1

Stratyfikacja ryzyka i określanie stadium zaawansowania

Po postawieniu diagnozy mięsaka tłuszczakowatego, konieczne jest określenie stadium zaawansowania nowotworu, co ma istotne znaczenie dla rokowania i planowania leczenia.1

System stopniowania TNM

Mięsaki tłuszczakowate są klasyfikowane przy użyciu systemu TNM (Tumor, Node, Metastasis) Amerykańskiego Wspólnego Komitetu ds. Raka (AJCC), który ocenia wielkość guza (T), zajęcie węzłów chłonnych (N) i obecność przerzutów odległych (M).1

Ocena stopnia złośliwości

Stopień złośliwości histologicznej jest najważniejszym czynnikiem prognostycznym w mięsaku tłuszczakowatym. Opiera się on na ocenie, jak bardzo komórki nowotworowe różnią się od normalnych komórek, jak szybko rosną i czy nowotwór się rozprzestrzenił.12

W przypadku śluzowatego mięsaka tłuszczakowatego obecność znaczącego (5% lub więcej) komponentu komórek okrągłych jest związana z gorszym rokowaniem. Pięcioletnie przeżycie u pacjentów z czystym komponentem śluzowatym lub mniej niż 5% komponentem komórek okrągłych wynosi 92%, podczas gdy przy znaczącym komponencie komórek okrągłych spada do 74%.1

Dodatkowe badania obrazowe

Po początkowej diagnozie mięsaka tłuszczakowatego, dodatkowe badania obrazowe mogą być przeprowadzone w celu określenia zasięgu choroby i potencjalnych przerzutów. Najczęstszym miejscem przerzutów mięsaka tłuszczakowatego są płuca, dlatego często wykonuje się tomografię komputerową klatki piersiowej.12

Znaczenie zespołu wielospecjalistycznego w diagnostyce

Ze względu na rzadkość i złożoność mięsaka tłuszczakowatego, istotne jest, aby diagnoza była postawiona przez zespół specjalistów z doświadczeniem w leczeniu mięsaków tkanek miękkich.12

Badania wykazały, że skierowanie pacjentów z podejrzeniem mięsaka tkanek miękkich do ośrodka specjalistycznego w celu diagnostyki prowadzi do lepszych wyników, mniejszej liczby przerzutów i ogólnie mniejszej liczby resekcji.1

Multidyscyplinarne podejście obejmujące onkologów, radiologów, patologów i chirurgów jest niezbędne dla zapewnienia dokładnej diagnozy i opracowania dostosowanego planu leczenia opartego na specyficznych cechach guza i ogólnym stanie zdrowia pacjenta.1

Wyzwania diagnostyczne i błędy w rozpoznaniu

Diagnoza mięsaka tłuszczakowatego może być wyzwaniem ze względu na jego rzadkość i złożoność, co prowadzi do błędnych diagnoz i opóźnień w dostępie do odpowiedniej terapii. Mięsaki są początkowo błędnie diagnozowane w około 30% przypadków.12

Mięsaki tłuszczakowate mogą być trudne do odróżnienia od łagodnych guzów tłuszczowych, nawet pod mikroskopem. Podobnie odróżnicowany mięsak tłuszczakowaty może być trudny do odróżnienia od praktycznie każdego innego typu mięsaka.1

W niektórych przypadkach pewne reakcje tkankowe mogą naśladować mięsaka tłuszczakowatego, jak na przykład późne reakcje ziarniniakowe wywołane przez silikon, które mogą prowadzić do nieprawidłowej diagnozy.1

Nowe kierunki w diagnostyce mięsaka tłuszczakowatego

Badania nad nowymi metodami diagnostycznymi mięsaka tłuszczakowatego koncentrują się na zwiększeniu dokładności diagnozy i zmniejszeniu czasu oczekiwania na wyniki.1

Połączenie technik sztucznej inteligencji z radiomiką może stanowić nowe podejście do diagnostyki rzadkich chorób, takich jak mięsaki tkanek miękkich. Radiomika w połączeniu z AI ma potencjał do poprawy klasyfikacji ryzyka mięsaków tkanek miękkich, planowania leczenia i monitorowania.1

Jeśli radiomika umożliwiłaby rozróżnienie stopnia złośliwości mięsaka tłuszczakowatego, możliwe byłoby wczesne zdiagnozowanie ryzyka przerzutów u pacjentów z nowotworem o wysokim stopniu złośliwości i w konsekwencji określenie dalszego przebiegu leczenia.1

Badacze opracowali również trójgenowy podpis metaboliczny, który umożliwia dokładną diagnozę różnicową między dobrze zróżnicowanym a odróżnicowanym mięsakiem tłuszczakowatym, nawet w próbkach zawierających krople lipidowe, co czyni go bardzo odpowiednim do stosowania na biopsjach.1

Podsumowanie diagnostyki mięsaka tłuszczakowatego

Diagnostyka mięsaka tłuszczakowatego wymaga kompleksowego podejścia łączącego ocenę kliniczną, badania obrazowe oraz analizę histopatologiczną i molekularną próbek tkankowych. Wczesne wykrycie i dokładna diagnoza są kluczowe dla skutecznego leczenia i poprawy rokowania pacjentów z tym rzadkim nowotworem.12

Mięsak tłuszczakowaty stanowi heterogeniczną grupę nowotworów o różnorodnej morfologii i potencjale do agresywnego zachowania. Dokładna diagnoza jest niezbędna dla określenia najbardziej odpowiedniego leczenia, które zwykle obejmuje chirurgiczne usunięcie guza, często w połączeniu z radioterapią i/lub chemioterapią w zależności od podtypu nowotworu i jego stadium zaawansowania.12

Metoda diagnostyczna Zastosowanie Zalety Ograniczenia
Badanie kliniczne Wstępna ocena guza Nieinwazyjne, szybkie Niespecyficzne, niewystarczające do postawienia diagnozy
Rezonans magnetyczny (MRI) Ocena charakterystyki guza, relacji z otaczającymi strukturami Doskonałe obrazowanie tkanek miękkich, brak promieniowania Wysoki koszt, ograniczona dostępność, przeciwwskazania u pacjentów z implantami metalowymi
Tomografia komputerowa (CT) Ocena wielkości, lokalizacji guza, wykrywanie przerzutów Szybkie wykonanie, dobra ocena struktur kostnych Ekspozycja na promieniowanie, mniejsza czułość dla tkanek miękkich niż MRI
Pozytonowa tomografia emisyjna (PET) Ocena stopnia zaawansowania, wykrywanie przerzutów Wysoka czułość w wykrywaniu aktywnych metabolicznie tkanek Wysoki koszt, ograniczona dostępność, ekspozycja na promieniowanie
Biopsja gruboigłowa Uzyskanie materiału do oceny histologicznej Mniej inwazyjna niż biopsja otwarta, dokładniejsza niż biopsja cienkoigłowa Możliwość błędu próbkowania, niewystarczająca ilość materiału
Biopsja chirurgiczna Uzyskanie większej ilości materiału do oceny histologicznej Większa ilość materiału, możliwość całkowitego usunięcia małych guzów Inwazyjność, dłuższy czas rekonwalescencji, potencjalnie wyższe ryzyko komplikacji
Immunohistochemia (IHC) Ocena ekspresji białek charakterystycznych dla mięsaka tłuszczakowatego Pomocna w różnicowaniu podtypów Niejednoznaczna interpretacja, niewystarczająca specyficzność
Fluorescencyjna hybrydyzacja in situ (FISH) Wykrywanie specyficznych zmian genetycznych Wysoka specyficzność dla określonych podtypów Wysoki koszt, czasochłonność, wymagania sprzętowe
Test NanoString Ocena ekspresji genów charakterystycznych dla mięsaka tłuszczakowatego Szybkie wyniki (36 godzin), wysoka zgodność ze standardowymi testami Ograniczona dostępność, nowsza technologia o mniejszej liczbie badań potwierdzających

Wczesna i dokładna diagnoza mięsaka tłuszczakowatego wymaga wielodyscyplinarnego podejścia i zaangażowania specjalistów z doświadczeniem w diagnostyce i leczeniu rzadkich nowotworów. Ze względu na różnorodność podtypów mięsaka tłuszczakowatego, które wymagają różnych strategii leczenia, dokładna diagnoza histopatologiczna i molekularna jest niezbędna dla optymalizacji opieki nad pacjentem.12

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 12.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Liposarcoma: A Journey into a Rare Tumor’s Epidemiology, Diagnosis, Pathophysiology, and Limitations of Current Therapies
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11592651/
    Sarcoma diagnosis is challenging because of its rarity and complexity, leading to misdiagnosis and delays in diagnosis and access to appropriate therapy. […] The initial diagnostic workup for LS includes cross-sectional imaging, such as magnetic resonance imaging (MRI) or computed tomography (CT). […] In addition to imaging, clinical guidelines recommend sarcoma diagnosis based on histologic examination, preferably by an experienced sarcoma pathologist. […] A core needle biopsy is the preferred method for obtaining a sample for histologic evaluation, as it is more accurate for defining grade and histologic subtype than fine needle aspiration. […] Furthermore, the integration of histopathology, immunohistochemistry (IHC), and molecular testing is essential for accurate diagnosis and in guiding clinical management.
  • #1 Liposarcoma | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/liposarcoma?lang=us
    Liposarcomas are malignant tumors of fatty tissue and are the malignant counterpart to a benign lipoma. They are the second most common soft tissue sarcoma, after undifferentiated pleomorphic sarcoma. […] Symptoms vary by tumor location, usually a mass is described when involving the subcutaneous tissues and extremities, and a vague discomfort when intra-abdominal or intrathoracic. […] CT findings favoring a liposarcoma over a lipoma include inhomogeneous attenuation, with evidence of significant amounts of soft-tissue within the fatty mass, poor definition of adjacent structures, evidence of infiltration or invasion of mediastinal structures, and calcification. […] Both treatment and prognosis vary with location and grade. […] High-grade lesions, especially those of the retroperitoneum, have a poor prognosis, with a recurrence rate of ~75% (range 63-91%). […] General imaging differential considerations include lipoma, undifferentiated pleomorphic sarcoma (UPS), formerly called malignant fibrous histiocytoma (MFH), and other sarcomas, e.g. fibrosarcoma, leiomyosarcoma.
  • #1 Liposarcoma Symptoms, Prognosis & Treatment
    https://www.medicinenet.com/liposarcoma/article.htm
    How is liposarcoma diagnosed? Many patients with liposarcoma will complain of a mass that they can feel. The mass can be soft and fleshy or even firm to palpation. Some doctors may initially try ultrasound, but the diagnosis usually requires standard X-rays that will help show whether or not any bony elements are involved. However, an MRI is usually obtained and may help suggest a diagnosis that must be confirmed by a biopsy. For many individuals, a chest CT is done because the chest is the most common site of metastasis (spread) of liposarcomas. […] The prognosis of liposarcomas varies with the type and location of the tumors. Extremity tumors that are appropriately treated have a good prognosis as do the well-differentiated types and myxoid type tumors. However, round-cell and poorly differentiated cell types have a poor prognosis with a survival rate of about 50% over five years. […] Most liposarcomas develop in people with no known risk factors. Consequently, there is no way to prevent liposarcomas other than to avoid exposure to their risk factors listed above.
  • #1 Liposarcoma – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/liposarcoma/diagnosis-treatment/drc-20352635
    Tests and procedures used to diagnose liposarcoma include: […] Imaging tests create pictures of the inside of the body. They might help show the size of the liposarcoma. Tests may include X-ray, CT scan and MRI. Sometimes a positron emission tomography scan, also called a PET scan, is needed. […] A procedure to remove some cells for testing is called a biopsy. The sample might be removed with a needle put through the skin. Or the sample might be taken during surgery to remove the cancer. The type of biopsy depends on the cancer’s location. […] The biopsy sample goes to a lab for testing. Doctors who specialize in analyzing blood and body tissue, called pathologists, test the cells to see if they’re cancerous. Other special tests give more details. Your health care team uses the results to understand your prognosis and create a treatment plan.
  • #1 ESR Member Area
    https://portal.myesr.org/esr/membership/publicposter/27a3318e-f15d-4390-ad24-a1042d42a9b2/show/results
    Magnetic resonance imaging (MRI) is considered the imaging modality of choice for evaluating soft tissue tumors, including liposarcomas, due to its superior soft tissue contrast resolution. On MRI, liposarcomas typically demonstrate hyperintense signal intensity on T1-weighted images due to the presence of adipose tissue, which appears hypointense on T2-weighted images. However, the signal intensity of liposarcomas may vary depending on their histological subtype and the proportion of adipose and non-adipose components. High-grade liposarcomas may exhibit heterogeneous signal intensity on both T1- and T2-weighted images due to areas of necrosis, hemorrhage, or cellular proliferation. Post-contrast MRI imaging demonstrates heterogeneous enhancement within the tumor, reflecting the presence of viable tumor tissue and neovascularization.
  • #1 Liposarcoma: Symptoms, Diagnosis, & Treatment Options
    https://sarcomaoncology.com/types-of-sarcoma/soft-tissue-sarcomas/liposarcoma/
    Procedures and tests that your oncologist may use to diagnose liposarcoma include: […] Imaging tests create pictures of the inside of the body, and help show the size of the liposarcoma. A CT scan may assess the location of a mass and its relationship to surrounding tissues. […] An MRI can show the characteristics of the tumor, which may help determine the diagnostic differences between benign and malignant soft tissue masses. […] Biopsy or removal of a tissue sample for testing is the most critical step in diagnosing liposarcoma. The sample may be removed by needle or through surgery. […] The sample is then tested in a lab to identify whether the tissue is benign or malignant. The type of biopsy your doctor performs will depend on the tumors location.
  • #1 Liposarcoma: Symptoms, Causes, Treatment & Prognosis
    https://my.clevelandclinic.org/health/diseases/21142-liposarcoma
    Liposarcoma is a group of very rare cancers that usually begin in fat cells in your arms and legs. Healthcare providers treat liposarcoma with surgery to remove tumors. Some types of liposarcoma may come back, requiring additional treatment and long-term follow up to catch new tumors before they can spread. […] Providers begin a diagnosis by doing a physical examination and asking about symptoms. Tests they may use include: […] Computed tomography (CT) scan: CT scans help providers locate tumors, including how close they are to major organs, and to evaluate tumor size. […] Magnetic resonance imaging (MRI): MRI scans help providers check on nearby nerves, blood vessels and muscles that may be affected by a liposarcoma. […] Biopsy: Providers take tumor tissue samples so medical pathologists can examine tumor cells under a microscope.
  • #1 Liposarcoma: Symptoms, Causes, Stages, Diagnosis and Treatment – OncoDaily
    https://oncodaily.com/oncolibrary/cancer-types/liposarcoma
    Diagnosing liposarcoma involves a combination of imaging techniques and biopsy procedures to accurately determine tumor type, location, and its relationship to surrounding structures. […] MRI utilizes magnetic fields and radio waves to produce detailed images of soft tissues. It is particularly effective in assessing the extent of the tumor and its proximity to vital structures such as major organs and nerves. This information is crucial for surgical planning and determining the feasibility of complete tumor resection. […] CT scans employ X-rays to generate cross-sectional images of the body. They are valuable in evaluating the tumors size, location, and involvement with adjacent structures. CT scans are also instrumental in detecting metastasis, particularly in the lungs, which is a common site for liposarcoma spread.
  • #1 Liposarcoma: Symptoms, Causes, Stages, Diagnosis and Treatment – OncoDaily
    https://oncodaily.com/oncolibrary/cancer-types/liposarcoma
    This procedure involves using a hollow needle to extract a tissue sample from the tumor. Imaging guidance, such as CT or ultrasound, is often employed to ensure accurate needle placement, especially for deep-seated tumors. The obtained tissue is then analyzed histologically to confirm the diagnosis and determine the specific liposarcoma subtype. […] Genetic testing plays a crucial role in accurately diagnosing liposarcoma subtypes and guiding treatment strategies. Molecular analyses can identify specific genetic alterations, such as amplifications of the MDM2 and CDK4 genes, which are characteristic of certain liposarcoma subtypes. These genetic markers are instrumental in distinguishing malignant liposarcomas from benign lipomas. […] A study by S. Pilotti et al. in The Journal of Pathology investigated the expression of MDM2 and CDK4 gene products in differentiating well-differentiated liposarcomas from large deep-seated lipomas. The research found that immunohistochemical analysis of these markers could assist in the differential diagnosis, as overexpression of MDM2 and CDK4 is more prevalent in malignant tumors.
  • #1 Liposarcoma: Causes, Symptoms, Diagnosis, and Treatment Options • Yesil Health
    https://yesilhealth.com/your-health/liposarcoma-causes-symptoms-diagnosis-and-treatment-options/
    Liposarcoma is a type of cancer that develops in the fat cells of the body. […] It is essential to understand the symptoms, diagnosis, and treatment options for liposarcoma to ensure timely and effective management of the condition. […] Diagnosing liposarcoma typically involves a combination of the following steps: A thorough medical history and physical examination are essential in identifying any symptoms or abnormalities. Your doctor may ask about your symptoms, medical history, and family history. […] Imaging tests, such as: Computed Tomography (CT) scan: uses X-rays and computer technology to produce detailed cross-sectional images of the body. Magnetic Resonance Imaging (MRI) scan: uses a strong magnetic field and radio waves to produce detailed images of the body. Positron Emission Tomography (PET) scan: uses small amounts of radioactive material to identify areas of high metabolic activity, which can indicate cancer.
  • #1 Liposarcoma Ultrasound Pictures: Diagnosis, Symptoms, Treatment
    https://www.emedicinehealth.com/can_liposarcoma_be_seen_on_ultrasound/article_em.htm
    Liposarcoma can be seen on an ultrasound, which can be used to diagnose the cancer and determine what type it is. […] One of the diagnostic imaging tests used to diagnose liposarcoma includes ultrasound. In some cases, ultrasound can be used to help differentiate the type of liposarcoma based on the characteristics found on the sonogram. […] Liposarcoma is diagnosed with a physical examination. Tests used to help confirm the diagnosis include: ultrasound.
  • #1 Liposarcoma Diagnosis: Tests and Stages
    https://www.webmd.com/cancer/liposarcoma-testing-diagnosis
    A new or growing lump under your skin can be a symptom of liposarcoma, a type of cancer that starts in fat cells. […] If you do have liposarcoma, the earlier you get a diagnosis, the sooner you can start treatment. […] A biopsy is the only way to know for sure that you have liposarcoma. […] Your doctor will use the results of these tests to confirm whether you have liposarcoma and where it is in your body. They’ll give your cancer a grade and stage based on how different it looks from normal cells, how fast it grows, and whether it has spread. […] Based on the grade and stage of your cancer, your doctor will tell you what to expect and create a personalized treatment plan.
  • #1 Liposarcoma Workup: Procedures, Histologic Findings, Staging
    https://emedicine.medscape.com/article/1102007-workup
    Preoperative biopsy is important in planning therapy. The diagnostic procedure of choice for liposarcoma is open biopsy. With superficial, small, fatty tumors, excisional biopsy is recommended for diagnosis. In large (3 cm) and deep tumors, diagnosis and treatment may involve open incisional biopsy followed by definitive resection. […] Fine-needle aspiration or biopsy should be followed by histologic and immunohistochemical examination. Adjunctive tests for MDM2 (murine double minute 2) may be helpful to distinguish liposarcoma from benign fatty neoplasms, but cutaneous and subcutaneous pleomorphic liposarcoma is less likely to demonstrate amplification. […] The recognition of lipoblasts is the key finding in the diagnosis of liposarcoma. A lipoblast has the ability to produce and accumulate nonmembrane-bound lipid within its cytoplasm. […] Surgical staging is appropriate only after the diagnosis is established and the oncologic stage is determined.
  • #1 Liposarcoma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538265/
    Liposarcomas arise from lipocytes found in soft tissues such as the esophagus, retroperitoneum, and popliteal fossa. […] This activity reviews the treatment, management, and follow-up of esophageal liposarcomas and the importance of interprofessional care coordination in treatment and follow-up. […] Describe the histological diagnosis of liposarcoma. […] Summarize the diagnostic evaluation required to make the diagnosis of liposarcoma. […] Different radiology diagnostic modalities such as barium swallow, computed tomography (CT) scan, magnetic resonance imaging (MRI) and esophagogastroduodenoscopy, can be used to diagnose liposarcoma. […] A definitive diagnosis can only be achieved by tissue examination. […] Pre-operative open biopsy with a subsequent histologic and immunohistochemical evaluation of the specimen is crucial for treatment planning.
  • #1 Liposarcoma | Sarcoma UK
    https://sarcoma.org.uk/about-sarcoma/what-is-sarcoma/types-of-sarcoma/liposarcoma/
    There are an average of 454 cases of liposarcoma diagnosed every year in England. […] Although liposarcoma can affect anyone of any age, the median age at diagnosis is 65 years old. […] WDLS is the most common subtype of liposarcoma, making up about 50% of all liposarcoma diagnoses. […] Dedifferentiated liposarcoma (DDLS) progresses from well-differentiated liposarcoma. […] Myxoid liposarcoma is a type of liposarcoma that is most frequently found in the limbs. […] Pleomorphic liposarcoma is a rare, fast-growing tumour.
  • #1 Liposarcoma: Symptoms, Causes, Treatment & Prognosis
    https://my.clevelandclinic.org/health/diseases/21142-liposarcoma
    Molecular and genetic testing: These tests determine the liposarcoma type. […] Liposarcoma treatment depends on the liposarcoma type, whether the cancer has spread and, if so, where it has spread. You may have a combination of more than one type of treatment for the disease. Treatments may include: […] Surgery: A surgeon removes the tumor and surrounding healthy tissue, including microscopic tumor cells. […] Radiation therapy: You may have radiation therapy to shrink the tumor before surgery, particularly if you have myxoid liposarcomas. You may also have this treatment after surgery to reduce the risk of the cancer coming back. […] Chemotherapy: Healthcare providers may use chemotherapy to treat tumors that surgery cant remove. […] Healthcare providers typically treat liposarcoma with surgery to remove the tumor and nearby healthy tissue. Any type of surgery may have complications. […] Each liposarcoma type is different, so your healthcare provider is your best resource for information about what you may expect, given your situation.
  • #1 Liposarcoma differential diagnosis – wikidoc
    https://www.wikidoc.org/index.php/Liposarcoma_differential_diagnosis
    Liposarcoma must be differentiated from other diseases that cause a painless, growing mass such as spindle cell lipoma, neurofibroma, dermatofibrosarcoma protuberans, and malignant peripheral nerve sheath tumor. […] MRI is the best radiologic tool to differentiate between retroperitoneal masses. […] Atypical lipomatous tumor/well differentiated liposarcoma and dedifferentiated liposarcoma are associated with: Presence of a large/giant marker chromosome and/or ring chromosomes at 12q13-15 region. […] Myxoid liposarcoma is associated with: t(12:16)(q13;p11) – CHOP(DDIT3) / FUS or t(12;22)(q13;q22) – CHOP(DDIT3) / EWS. […] Pleomorphic liposarcoma is associated with: Complex karyotypic aberrations. […] Well-differentiated liposarcoma: Sclerosing liposarcoma (distinctive stromal cells distributed across the tissue, associated with lipoblasts filled with multiple vacuoles, and collagenous background of fibrillary appearance).
  • #1 New Test Provides Fast and Accurate Diagnosis of Liposarcomas | Today’s Clinical Lab
    https://www.clinicallab.com/new-test-provides-fast-and-accurate-diagnosis-of-liposarcomas-25105
    Researchers have leveraged the latest advances in RNA technology and machine learning methods to develop a gene panel test that allows for highly accurate diagnosis of the most common types of liposarcoma. It quickly and reliably distinguishes benign lipomas from liposarcomas and can be performed in laboratories at a lower cost than current „gold standard” tests. […] „Liposarcomas are a type of malignant cancer that is difficult to diagnose because, even under a microscope, it is hard to differentiate liposarcomas from benign tumors or other types of cancer that need different treatments,” explains lead investigator Torsten Owen Nielsen, MD, PhD, Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. […] Among the current recommended diagnostic tests for liposarcomas, immunohistochemistry (IHC) is inaccurate and hard to interpret, and fluorescence in situ hybridization (FISH) is relatively expensive, as well as labor- and equipment-intensive.
  • #1 New Test Provides Fast and Accurate Diagnosis of Liposarcomas | Today’s Clinical Lab
    https://www.clinicallab.com/new-test-provides-fast-and-accurate-diagnosis-of-liposarcomas-25105
    The retrospective and prospective cases probed by the NanoString assay had a 93 percent success rate and agreed with standard tests 97.8 percent of the time. Results from the NanoString assay were available in 36 hours, whereas it took between one to two weeks to get FISH results. NanoString costs amounted to US$270 per case, factoring in reagents, labor, and equipment maintenance.
  • #1 A scoring system combining clinical, radiological, and histopathological examinations for differential diagnosis between lipoma and atypical lipomatous tumor/well-differentiated liposarcoma | Scientific Reports
    https://www.nature.com/articles/s41598-021-04004-1
    This study evaluated the diagnostic accuracy of clinical, radiological, and histopathological examinations for differential diagnosis between atypical lipomatous tumor (ALT)/well-differentiated liposarcoma (WDLS) and lipoma, and aimed to develop a new combined scoring system for the preoperative diagnosis of ALT/WDLS. […] The univariate and multivariate logistic regression analyses revealed that tumor location (lower extremity), deep site, size (11 cm), thick septa (2 mm), enhancement of septa or nodular lesions, and lipoblasts were significantly different for the diagnosis of ALT/WDLS. […] We developed a combined scoring system based on the six predictive factors (total 016 points, the cutoff was 9 points). […] The area under the curve was 0.945, and sensitivity was 87.6% and specificity was 91.1% by the receiver operating characteristics curve.
  • #1 Accurate 3-gene-signature for early diagnosis of liposarcoma progression | Clinical Sarcoma Research | Full Text
    https://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-020-0126-1
    Well- and dedifferentiated liposarcoma (WD/DDLPS) are rare mesenchymal malignant tumors that account for 20% of all sarcomas in adults. Currently the final differential diagnosis to distinguish between more aggressive and less aggressive form is based on post-surgical histological examination and no molecular biomarkers for early detection are available. […] We established a three-gene signature based on PNPLA2, LIPE and PLIN1, which identified DDLPS with 100% sensitivity and 90% specificity, even in specimens from the WD component of DDLPS tumors. […] The identified metabolic signature allows highly accurate differential diagnosis between WD- and DDLPS even in samples containing lipid droplets, a marker of differentiation, which makes it very suitable for the use on biopsies. […] Here we tested a metabolic gene signature as a biomarker for the differential diagnosis of ALT/WD- and DDLPS, as well as for its ability to predict malignant evolution towards the DD form.
  • #1 Myxoid liposarcoma: Diagnosis, treatment and prognosis | MD Anderson Cancer Center
    https://www.mdanderson.org/cancerwise/myxoid-liposarcoma–diagnosis–treatment-and-prognosis.h00-159700701.html
    Myxoid liposarcoma is a rare cancer that accounts for about 30% to 40% of liposarcoma cases. This makes it the second most common type of liposarcoma. […] It’s important to get a correct diagnosis of myxoid liposarcoma. Some people have myxoid liposarcoma for a while and don’t know it. This is because a lump may not appear until the tumor has grown large enough to cause concern. […] Your doctor will do some form of imaging, such as an ultrasound, X-ray, CT scan or MRI. If a mass is detected, your doctor needs to order a biopsy. If your doctor doesn’t order a biopsy after scans show a mass, they might miss the diagnosis. […] Instead, with a biopsy, they can test the tissue and determine if it’s cancer. If it is myxoid liposarcoma, seek care at a comprehensive cancer center like MD Anderson which has doctors who specialize in treating this type of cancer.
  • #1 Myxoid Liposarcoma – Sarcoma Oncology Center
    https://sarcomaoncology.com/types-of-sarcoma/soft-tissue-sarcomas/liposarcoma/myxoid-liposarcoma/
    Many people with myxoid liposarcoma may not realize they have it because a lump might not appear until the tumor grows large enough to be noticeable. […] If the lump isnt causing pain, its easy to overlook. However, we advise you to see your doctor if you notice any new or unusual lumps. […] At Sarcoma Oncology Center, our oncologist may begin with a physical examination and ask about symptoms. We may suggest the following tests for the diagnosis of myxoid liposarcoma: […] If MLPS is suspected, we may ask for imaging tests like CT or MRI scans to determine the tumor’s size, location, and whether it has spread to other areas of the body. […] To confirm if the tumor is MLPS, you may need a biopsy. This involves using a needle to take a small tissue sample from the tumor. The sample is then examined under a microscope to identify the type of tumor and confirm the diagnosis. […] Myxoid liposarcoma requires a specialized approach for accurate diagnosis and effective treatment. At Sarcoma Oncology Center, our team of specialists provides comprehensive, evidence-based sarcoma care tailored to each case to ensure the best possible outcomes.
  • #1 Liposarcoma differential diagnosis – wikidoc
    https://www.wikidoc.org/index.php/Liposarcoma_differential_diagnosis
    De-differentiated liposarcoma: Myxoid liposarcoma (non-homogenous appearance with cystic and solid components). […] Atypical lipomatous tumor/well differentiated liposarcoma is positive for: MDM2, CDK4, p16, S100 (stains adipocytes and lipoblasts). […] Retroperitoneal liposarcoma may be asymptomatic or causes: Weight loss, Abdominal pain, Oliguria, renal failure (due to ureters or kidneys’ compression), Palpable abdominal mass, Abdominal tenderness, Abdominal distention. […] Esophageal liposarcoma may cause: Dysphagia, Vomiting, Cough, Gastrointestinal bleeding, Hoarseness. […] Bowel liposarcoma may cause: Gastrointestinal bleeding. […] Mediastinal liposarcoma may cause: Dyspnea, Cough, Chest pain, Weight loss.
  • #1 Myxoid liposarcoma of the right lower limb – MedCrave online
    https://medcraveonline.com/HTIJ/myxoid-liposarcoma-of-the-right-lower-limb.html
    It is known that the diagnosis of these tumors can be delayed due to the lack of specific symptoms, and this delay in diagnosis and the large size that these lesions can reach significantly influence the prognosis and treatment of the disease, sometimes putting in danger, the functional preservation of the affected limb. […] To make the diagnosis we must use different imaging methods. Simple radiography is of little use, it can demonstrate an increase in soft tissues, usually non-specific. […] Both computed tomography (CT) and magnetic resonance imaging (MRI) are useful and are recommended for the pre operative evaluation of lesions and the follow up after treatment; there are no great advantages in either technique. […] The pathological diagnosis was myxoid liposarcoma. […] Myxoid liposarcoma is usually an indolent disease; a small percentage of patients develop soft tissue metastases years after the initial diagnosis, which represents a worse prognosis.
  • #1 Orphanet: Myxoid/round cell liposarcoma
    https://www.orpha.net/en/disease/detail/99967
    Myxoid/round cell liposarcoma (MRCLS) is a type of liposarcoma (LS) mostly located in the limbs, with a variable behavior depending on the histological subtype. Both myxoid and round cell are distinct histological subtypes of LS. […] When a mass is detected, computed tomography (CT) or magnetic resonance imaging (MRI) is performed. […] Extremity lesions are generally sampled by multiple core biopsies to identify the histological subtype (myxoid versus round cell component) and to stage the disease. […] The diagnosis can be confirmed by evidence of the DDIT3-FUS translocation from fluorescence in situ hybridization (FISH) or RT-PCR. […] MRCLS can be mistaken for Ewing sarcoma, lymphoma and pleomorphic undifferentiated sarcomas. […] Treatment involves the surgical excision of the tumor and surrounding tissue for low grade myxoid liposarcoma.
  • #1 Liposarcoma – Rein in Sarcoma
    https://www.reininsarcoma.org/liposarcoma/
    Liposarcomas are often painless and slow-growing, so diagnosis can be delayed, especially if located in the retroperitoneum. […] If there is any suspicion for a liposarcoma or other soft tissue sarcoma (STS), patients should be referred to a soft tissue sarcoma specialty center for diagnosis and care. […] Studies have shown that referring patients with suspected soft tissue sarcoma (STS) to a specialty center for diagnosis leads to better outcomes, less metastases, and fewer excisions overall. […] Location determines the imaging technique used to best visualize the tumor. […] A biopsy may be performed to confirm the diagnosis and may influence treatment options. […] Molecular testing is often performed to further describe the tumors and may provide prognostic value. […] Liposarcomas are classified using the American Joint Committee on Cancer (AJCC) Staging Manual that utilizes the T (tumor), N (node), and M (metastasis) standard to describe the overall spread of the tumor.
  • #1 Final Diagnosis — Case 302
    https://path.upmc.edu/cases/case302/dx.html
    FINAL DIAGNOSIS: POORLY DIFFERENTIATED LIPOSARCOMA WITH SPINDLE CELL, ROUND CELL COMPONENTS AND FOCAL OSSEOUS AND CHONDROID METAPLASIA […] Liposarcoma is one of the most common soft tissue sarcoma in adults. […] The common morphologic denominator of liposarcoma is the lipoblasts. […] Well-differentiated liposarcoma is the most common form with a peak incidence during sixth and seventh decades of life. […] Dedifferentiated liposarcomas develop in approximately the same age group as well-differentiated liposarcomas, reaching a peak during the early seventh decade. […] Myxoid and round cell liposarcomas are considered as poorly differentiated and they account for one-half of liposarcomas. […] Cytogenetically, 77% of myxoid liposarcomas are associated with a chromosomal translocation, t(12; 16) (q13; p11). […] Histologic grade is the most important prognostic factor.
  • #1 Orphanet: Myxoid/round cell liposarcoma
    https://www.orpha.net/en/disease/detail/99967
    High grade round cell LS that is large (5 cm), or marginally resectable tumors, may be treated with pre-operative chemotherapy and/or pre-operative or post-operative radiotherapy. […] The prognosis of MRCLS is good for patients with low grade myxoid liposarcoma (defined as pure myxoid or less than a 5% round cell component), the 5-year survival rate is 92%. A significant (5% or greater) round cell component is associated with a much poorer prognosis, with a 5-year survival rate of 74%.
  • #1 Liposarcoma: A Journey into a Rare Tumor’s Epidemiology, Diagnosis, Pathophysiology, and Limitations of Current Therapies
    https://www.mdpi.com/2072-6694/16/22/3858
    Furthermore, the integration of histopathology, immunohistochemistry (IHC), and molecular testing is essential for accurate diagnosis and in guiding clinical management. […] Sarcomas are initially misdiagnosed in ~30% of cases, leading to delays in appropriate treatment. […] Ancillary diagnostic testing, such as IHC and molecular genetic testing, plays a crucial role in differentiating LS subtypes, particularly when histologic findings are inconclusive. […] Importantly, genomic profiling along with detailed histologic examination may help reduce misdiagnoses of LS subtypes. […] Following the initial diagnosis of LS, additional imaging can determine the extent of disease and any potential metastases.
  • #1 Liposarcoma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK538265/
    Surgical excision is the mainstay of treatment. […] However, liposarcoma response to chemotherapy is not well documented. […] For esophageal liposarcoma, surgery can be either a minimally invasive endoscopic submucosal resection or an aggressive partial or total esophagectomy. […] Even with suggestive radiologic studies, the definitive diagnosis cannot be made without biopsy/resection. […] Addressing this pathology requires the efforts of an interprofessional team.
  • #1 Liposarcoma – Diagnosis & Disease Information
    https://www.cancertherapyadvisor.com/ddi/liposarcoma/
    Liposarcoma is a malignant tumor arising from adipose tissue that develops in the soft tissues of the body. […] Successful management of liposarcoma relies on early detection, accurate diagnosis, and prompt treatment with surgery, radiation therapy, and/or chemotherapy. […] Diagnosing liposarcoma requires a comprehensive approach that integrates clinical evaluation, imaging studies, and histopathological examination of tissue samples. […] A tissue biopsy obtained through surgical excision or needle biopsy is necessary for definitive diagnosis of liposarcoma. Histopathological examination will determine the tumors subtype and grade, which is crucial for treatment planning. […] Accurate histological subtyping through biopsy and, if possible, genetic analysis is essential for tailoring treatment plans. […] A multidisciplinary approach that includes oncologists, radiologists, pathologists, and surgeons is essential to ensure accurate diagnosis and develop a tailored treatment plan based on the specific characteristics of the tumor and the patients overall health.
  • #1 Liposarcoma: A Journey into a Rare Tumor’s Epidemiology, Diagnosis, Pathophysiology, and Limitations of Current Therapies
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11592651/
    Recently, genetic testing has helped modify the diagnostic workup for LS to facilitate the diagnosis of subtypes. […] Following the initial diagnosis of LS, additional imaging can determine the extent of disease and any potential metastases. […] Sarcomas are initially misdiagnosed in ~30% of cases, leading to delays in appropriate treatment. […] Ancillary diagnostic testing, such as IHC and molecular genetic testing, plays a crucial role in differentiating LS subtypes, particularly when histologic findings are inconclusive. […] Importantly, genomic profiling along with detailed histologic examination may help reduce misdiagnoses of LS subtypes. […] By improving diagnostic accuracy, ancillary diagnostics play a critical role in guiding clinicians toward more targeted and effective treatment strategies, ultimately leading to better patient outcomes.
  • #1 Liposarcomas of the mediastinum – Suster – Mediastinum
    https://med.amegroups.org/article/view/5725/html
    Liposarcoma is a malignant tumor of adipocytic differentiation that rarely arises within the mediastinum. […] On morphologic grounds liposarcoma can present a challenge for diagnosis as it can be difficult to distinguish from benign adipocytic neoplasms, or in the case of dedifferentiated liposarcoma (DDLS), from virtually any other type of sarcoma. […] MDM2 and CDK4 amplification can be assessed by immunohistochemistry, fluorescence in situ hybridization, or molecular techniques that evaluate copy number alterations and amplifications such as array based assays and next generation sequencing (NGS). […] The present review will focus on the clinicopathologic features of the various histologic types of liposarcoma described in the mediastinum and their differential diagnosis. […] The World Health Organization (WHO) recognizes four basic types of liposarcoma: well-differentiated/atypical lipomatous tumor (WDL/ALT), dedifferentiated, myxoid and pleomorphic liposarcoma (PLS).
  • #1 Liposarcoma Differential Diagnoses
    https://emedicine.medscape.com/article/1102007-differential
    Also consider the following: […] Late granulomatous reactions from silicone may appear in a site different from that of the injection and may cause an incorrect diagnosis of liposarcoma. […] Silicone implants for chin augmentation may create a tissue reaction that mimics a low-grade liposarcoma. […] Myxofibrosarcoma, one of the most common soft tissue sarcomas of elderly patients, may histologically resemble pleomorphic liposarcoma. […] Primary liposarcoma may be evident as metastatic liposarcoma to the head and neck region, including the gingival mucosa. […] Spindle cell lipomas are benign lipomatous tumors that may require histological distinction from liposarcoma. […] Because cutaneous liposarcoma is extremely rare, the physician must rule out a metastatic lesion.
  • #1 New test provides fast and accurate diagnosis of liposarcomas – ecancer
    https://ecancer.org/en/news/19601-new-test-provides-fast-and-accurate-diagnosis-of-liposarcomas
    Among the current recommended diagnostic tests for liposarcomas, immunohistochemistry (IHC) is inaccurate and hard to interpret, and fluorescence in situ hybridisation (FISH) is relatively expensive, as well as labour- and equipment-intensive. […] The retrospective and prospective cases probed by the NanoString assay had a 93 percent success rate and agreed with standard tests 97.8 percent of the time. Results from the NanoString assay were available in 36 hours, whereas it took between one to two weeks to get FISH results. […] Thus, the current study not only expands the types of sarcoma that can be diagnosed accurately with NanoString-based diagnostics, but also shows how a different category of mutation can be detected.
  • #1 Increasing differential diagnosis between lipoma and liposarcoma through radiomics: a narrative review
    https://www.explorationpub.com/Journals/etat/Article/1002147
    The imaging findings of PM-LPS are typically a large, relatively well-defined, nonspecific soft tissue mass with often infiltrative margins and heterogeneous signal intensity due to the presence of hemorrhage and/or necrosis. […] The conclusion of the radiological report should be written with caution. Due to overlap in imaging findings, the challenges of accurately distinguishing between lipoma and LPS must include information about anatomical location, tumor size, features of benignity or malignancy, and comorbidity. […] The ability to diagnose STSs utilizing radiomics and AI technology has the potential to be more precise and effective. There are, however, a number of issues that must be resolved, including the requirement for sizable and varied datasets, the standardization of imaging methods, and the validation of AI models in clinical settings. AI combined with radiomics has the potential to enhance STSs risk classification, treatment planning, and monitoring. […] If radiomics made it possible to distinguish the G of LPS, then it would be possible to diagnose the metastatic risk early in patients with a high-G neoplasm and consequently determine the subsequent course of treatment.
  • #1 Myxoid liposarcoma – Overview of Information and Clinical Research
    https://clinicaltrials.eu/disease/myxoid-liposarcoma/
    Chemotherapy is another critical component of MLPS treatment, especially for larger tumors, advanced cases, or when the cancer has metastasized. […] Treatment for MLPS is highly individualized, taking into account the tumor’s characteristics, the patient’s overall health, and whether the cancer has spread. […] Early diagnosis plays a crucial role in improving the prognosis for myxoid liposarcoma. Detecting the cancer before it spreads allows for more effective treatment options and better outcomes. […] The prognosis for myxoid liposarcoma is generally better when the tumor is detected and treated before it spreads.
  • #1 Liposarcomas of the mediastinum – Suster – Mediastinum
    https://med.amegroups.org/article/view/5725/html
    The tumors show a slight predilection for men (M/F: 1.3:1). […] The clinical behavior of these tumors is usually characterized by multiple recurrences, with death ensuing after many years due to compromise of local structures. […] The diagnosis of DDLS is facilitated using antibodies for MDM2, which will show scattered nuclear positivity in the spindle cells of the non-lipogenic component as well as in the neoplastic adipocytic component. […] The myxoid variant of liposarcoma may be harder to identify in some instances, particularly the hypercellular variant, and may require molecular testing to demonstrate the DDIT3 gene rearrangement. […] PLS remains an elusive diagnosis that may occasionally be arbitrarily applied due to the lack of distinct a molecular signature or immunohistochemical profile, and which will require further studies to better delineate its diagnostic criteria. […] Mediastinal liposarcomas comprise a heterogeneous group of tumors with diverse morphology that have the potential for highly aggressive behavior and patient death caused by tumor.
  • #2 Liposarcoma – Diagnosis & Disease Information
    https://www.cancertherapyadvisor.com/ddi/liposarcoma/
    Liposarcoma is a malignant tumor arising from adipose tissue that develops in the soft tissues of the body. […] Successful management of liposarcoma relies on early detection, accurate diagnosis, and prompt treatment with surgery, radiation therapy, and/or chemotherapy. […] Diagnosing liposarcoma requires a comprehensive approach that integrates clinical evaluation, imaging studies, and histopathological examination of tissue samples. […] A tissue biopsy obtained through surgical excision or needle biopsy is necessary for definitive diagnosis of liposarcoma. Histopathological examination will determine the tumors subtype and grade, which is crucial for treatment planning. […] Accurate histological subtyping through biopsy and, if possible, genetic analysis is essential for tailoring treatment plans. […] A multidisciplinary approach that includes oncologists, radiologists, pathologists, and surgeons is essential to ensure accurate diagnosis and develop a tailored treatment plan based on the specific characteristics of the tumor and the patients overall health.
  • #2 Liposarcoma: Symptoms, Causes, Treatment & Prognosis
    https://my.clevelandclinic.org/health/diseases/21142-liposarcoma
    Liposarcoma is a group of very rare cancers that usually begin in fat cells in your arms and legs. Healthcare providers treat liposarcoma with surgery to remove tumors. Some types of liposarcoma may come back, requiring additional treatment and long-term follow up to catch new tumors before they can spread. […] Providers begin a diagnosis by doing a physical examination and asking about symptoms. Tests they may use include: […] Computed tomography (CT) scan: CT scans help providers locate tumors, including how close they are to major organs, and to evaluate tumor size. […] Magnetic resonance imaging (MRI): MRI scans help providers check on nearby nerves, blood vessels and muscles that may be affected by a liposarcoma. […] Biopsy: Providers take tumor tissue samples so medical pathologists can examine tumor cells under a microscope.
  • #2 What are the symptoms of liposarcoma? | MD Anderson Cancer Center
    https://www.mdanderson.org/cancerwise/what-are-the-symptoms-of-liposarcoma.h00-159775656.html
    Liposarcoma is the most common type of soft tissue sarcoma, making up about 15% to 20% of diagnoses. […] When you visit your doctor with liposarcoma symptoms, your doctor will usually order a CT scan or MRI. […] If a cancer diagnosis is made, well often do next-generation sequencing to learn more about the tumors genetic characteristics. This will help us identify the specific type of liposarcoma and develop the best treatment plan. […] If something doesnt feel right or you have symptoms that are worsening, talk to your doctor.
  • #2 Liposarcoma Symptoms, Prognosis & Treatment
    https://www.medicinenet.com/liposarcoma/article.htm
    How is liposarcoma diagnosed? Many patients with liposarcoma will complain of a mass that they can feel. The mass can be soft and fleshy or even firm to palpation. Some doctors may initially try ultrasound, but the diagnosis usually requires standard X-rays that will help show whether or not any bony elements are involved. However, an MRI is usually obtained and may help suggest a diagnosis that must be confirmed by a biopsy. For many individuals, a chest CT is done because the chest is the most common site of metastasis (spread) of liposarcomas. […] The prognosis of liposarcomas varies with the type and location of the tumors. Extremity tumors that are appropriately treated have a good prognosis as do the well-differentiated types and myxoid type tumors. However, round-cell and poorly differentiated cell types have a poor prognosis with a survival rate of about 50% over five years. […] Most liposarcomas develop in people with no known risk factors. Consequently, there is no way to prevent liposarcomas other than to avoid exposure to their risk factors listed above.
  • #2 ESR Member Area
    https://portal.myesr.org/esr/membership/publicposter/27a3318e-f15d-4390-ad24-a1042d42a9b2/show/results
    Computed tomography (CT) is widely used for the initial evaluation of liposarcomas. On non-contrast CT scans, liposarcomas typically appear as well-defined soft tissue masses with varying degrees of fat attenuation due to their adipose tissue origin. The presence of mature adipose tissue within the tumor manifests as regions of low attenuation ( -30 Hounsfield Units) on CT images. However, some liposarcomas may contain non-adipose components, leading to heterogeneous attenuation patterns. Higher-grade liposarcomas may exhibit areas of necrosis, calcification, or hemorrhage, contributing to their heterogeneous appearance on CT scans. Contrast-enhanced CT imaging reveals heterogeneous enhancement within the tumor, particularly in the non-adipose regions, reflecting the presence of viable tumor tissue with increased vascularity. In Well-differentiated and dedifferentiated liposarcomas calcifications might be found.
  • #2 Delayed retroperitoneal liposarcoma diagnosis and management in a patient with massive obesity | European Journal of Clinical Nutrition
    https://www.nature.com/articles/s41430-020-00855-5
    People suffering from extreme obesity may be exposed to delayed diagnosis and treatment of cancer. […] An ultrasound-guided core needle biopsy was performed and was in favor of a liposarcoma. […] This case highlights the difficulties to screen, diagnose, and manage cancers encountered in patients suffering from massive obesity.
  • #2 Liposarcoma: Symptoms, Types, Treatment, Prognosis
    https://www.healthline.com/health/liposarcoma
    Liposarcoma begins when genetic changes occur in fat cells, causing them to grow out of control. […] The diagnosis can be made with a biopsy. A sample of tissue will need to be removed from the tumor. If the tumor is hard to reach, imaging tests such as an MRI or CT scan can be used to guide the needle to the tumor. […] Imaging tests can also help determine the size and number of tumors. These tests can also tell if nearby organs and tissues have been affected. […] The tissue sample will be sent to a pathologist, who will examine it under a microscope. The pathology report will be sent to your doctor. This report will tell your doctor whether the mass is cancerous, as well as details about the type of cancer.
  • #2 Liposarcoma Workup: Procedures, Histologic Findings, Staging
    https://emedicine.medscape.com/article/1102007-workup
    Preoperative biopsy is important in planning therapy. The diagnostic procedure of choice for liposarcoma is open biopsy. With superficial, small, fatty tumors, excisional biopsy is recommended for diagnosis. In large (3 cm) and deep tumors, diagnosis and treatment may involve open incisional biopsy followed by definitive resection. […] Fine-needle aspiration or biopsy should be followed by histologic and immunohistochemical examination. Adjunctive tests for MDM2 (murine double minute 2) may be helpful to distinguish liposarcoma from benign fatty neoplasms, but cutaneous and subcutaneous pleomorphic liposarcoma is less likely to demonstrate amplification. […] The recognition of lipoblasts is the key finding in the diagnosis of liposarcoma. A lipoblast has the ability to produce and accumulate nonmembrane-bound lipid within its cytoplasm. […] Surgical staging is appropriate only after the diagnosis is established and the oncologic stage is determined.
  • #2 Pathology Outlines – Liposarcoma
    https://www.pathologyoutlines.com/topic/testisliposarcoma.html
    Well differentiated and dedifferentiated liposarcomas are characterized by MDM2 amplifications and represent the vast majority of paratesticular liposarcomas. […] Other liposarcomas (myxoid liposarcoma, pleomorphic liposarcoma) are very rare in this location and are driven by other mechanisms of tumorigenesis. […] In conjunction with imaging findings, initial diagnosis can be made on targeted biopsy. […] Due to intratumoral heterogeneity, surgical resection is recommended for definitive classification. […] Ancillary testing may be needed in difficult cases.
  • #2
    https://tumorsurgery.org/tumor-education/soft-tissue-tumors/soft-tissue-tumor-types/well-differentiated-liposarcoma.aspx
    Liposarcoma is one of the most commonly diagnosed soft tissue sarcoma, accounting for approximately 12.8% of all sarcomas. Most patients are older than 50 years of age who complain of a large, painless, deep-seated mass located proximally in the extremities. Liposarcoma is a malignant mesenchymal neoplasm composed of lipogenic tissue with varying degrees of atypia. MRI is nonspecific except for well-differentiated tumors in which fat signal is easily distinguished. Different types of Liposarcoma have been described depending on their histology, including; well-differentiated liposarcoma (40%), myxoid liposarcoma/round cell liposarcoma (30%), pleomorphic (15%) and dedifferentiated liposarcoma (5%) with different clinical behavior. […] Well-differentiated liposarcoma is the most common subtype of liposarcoma. These tumors nearly always occur in adults and have no gender predilection. They arise most commonly in the deep soft tissues of the proximal extremities (Thigh) and the retroperitoneum.
  • #2 Myxoid liposarcoma: Diagnosis, treatment and prognosis | MD Anderson Cancer Center
    https://www.mdanderson.org/cancerwise/myxoid-liposarcoma–diagnosis–treatment-and-prognosis.h00-159700701.html
    Myxoid liposarcoma is a rare cancer that accounts for about 30% to 40% of liposarcoma cases. This makes it the second most common type of liposarcoma. […] It’s important to get a correct diagnosis of myxoid liposarcoma. Some people have myxoid liposarcoma for a while and don’t know it. This is because a lump may not appear until the tumor has grown large enough to cause concern. […] Your doctor will do some form of imaging, such as an ultrasound, X-ray, CT scan or MRI. If a mass is detected, your doctor needs to order a biopsy. If your doctor doesn’t order a biopsy after scans show a mass, they might miss the diagnosis. […] Instead, with a biopsy, they can test the tissue and determine if it’s cancer. If it is myxoid liposarcoma, seek care at a comprehensive cancer center like MD Anderson which has doctors who specialize in treating this type of cancer.
  • #2 Myxoid Liposarcoma: Causes, Treatment & Prognosis
    https://my.clevelandclinic.org/health/diseases/24731-myxoid-liposarcoma
    Myxoid liposarcoma is a subtype of liposarcoma, a group of very rare cancers that begin in fat cells. […] Healthcare providers treat the condition with surgery, chemotherapy and/or radiation therapy. […] Providers begin their diagnosis by doing a physical examination and asking about symptoms. Tests they may use include: […] Molecular and genetic testing: These tests confirm whether a tumor is a myxoid liposarcoma. […] Your provider may do one or a combination of the following treatments: […] Healthcare providers typically treat myxoid liposarcoma with surgery to remove the tumor and nearby healthy tissue. […] Unfortunately, no. Most people develop myxoid liposarcoma because they had radiation therapy for other types of cancer, including lymphoma, breast cancer or prostate cancer.
  • #2 Liposarcomas of the mediastinum – Suster – Mediastinum
    https://med.amegroups.org/article/view/5725/html
    Liposarcoma is a malignant tumor of adipocytic differentiation that rarely arises within the mediastinum. […] On morphologic grounds liposarcoma can present a challenge for diagnosis as it can be difficult to distinguish from benign adipocytic neoplasms, or in the case of dedifferentiated liposarcoma (DDLS), from virtually any other type of sarcoma. […] MDM2 and CDK4 amplification can be assessed by immunohistochemistry, fluorescence in situ hybridization, or molecular techniques that evaluate copy number alterations and amplifications such as array based assays and next generation sequencing (NGS). […] The present review will focus on the clinicopathologic features of the various histologic types of liposarcoma described in the mediastinum and their differential diagnosis. […] The World Health Organization (WHO) recognizes four basic types of liposarcoma: well-differentiated/atypical lipomatous tumor (WDL/ALT), dedifferentiated, myxoid and pleomorphic liposarcoma (PLS).
  • #2 Orphanet: Myxoid/round cell liposarcoma
    https://www.orpha.net/en/disease/detail/99967
    Myxoid/round cell liposarcoma (MRCLS) is a type of liposarcoma (LS) mostly located in the limbs, with a variable behavior depending on the histological subtype. Both myxoid and round cell are distinct histological subtypes of LS. […] When a mass is detected, computed tomography (CT) or magnetic resonance imaging (MRI) is performed. […] Extremity lesions are generally sampled by multiple core biopsies to identify the histological subtype (myxoid versus round cell component) and to stage the disease. […] The diagnosis can be confirmed by evidence of the DDIT3-FUS translocation from fluorescence in situ hybridization (FISH) or RT-PCR. […] MRCLS can be mistaken for Ewing sarcoma, lymphoma and pleomorphic undifferentiated sarcomas. […] Treatment involves the surgical excision of the tumor and surrounding tissue for low grade myxoid liposarcoma.
  • #2 New test provides fast and accurate diagnosis of liposarcomas – ecancer
    https://ecancer.org/en/news/19601-new-test-provides-fast-and-accurate-diagnosis-of-liposarcomas
    New test provides fast and accurate diagnosis of liposarcomas. Researchers have leveraged the latest advances in RNA technology and machine learning methods to develop a gene panel test that allows for highly accurate diagnosis of the most common types of liposarcoma. It quickly and reliably distinguishes benign lipomas from liposarcomas and can be performed in laboratories at a lower cost than current „gold standard” tests. „Liposarcomas are a type of malignant cancer that is difficult to diagnose because, even under a microscope, it is hard to differentiate liposarcomas from benign tumors or other types of cancer that need different treatments,” explains lead investigator Torsten Owen Nielsen, MD, PhD, Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • #2 New test provides fast and accurate diagnosis of liposarcomas
    https://medicalxpress.com/news/2021-02-fast-accurate-diagnosis-liposarcomas.html
    Among the current recommended diagnostic tests for liposarcomas, immunohistochemistry (IHC) is inaccurate and hard to interpret, and fluorescence in situ hybridization (FISH) is relatively expensive, as well as labor- and equipment-intensive. […] The retrospective and prospective cases probed by the NanoString assay had a 93 percent success rate and agreed with standard tests 97.8 percent of the time. Results from the NanoString assay were available in 36 hours, whereas it took between one to two weeks to get FISH results. […] This strategy may help develop diagnostics for other types of cancer.
  • #2 A scoring system combining clinical, radiological, and histopathological examinations for differential diagnosis between lipoma and atypical lipomatous tumor/well-differentiated liposarcoma | Scientific Reports
    https://www.nature.com/articles/s41598-021-04004-1
    Although there have been some reports regarding the usefulness and high accuracy of the assessment, such as fluorescence in situ hybridization (FISH) for murine double-minute 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) for the diagnosis of ALT/WDLS, these technologies require special equipment and reagents, so not all medical institutions can perform this examination. […] The assessment with MRI and hematoxylin and eosin (HE) staining remains the standard method of diagnosis for adipocytic tumors, so it is crucial to determine the diagnosis by a comprehensive assessment of clinical, radiological, and histopathological examinations. […] In this study, nuclear atypia had a significant difference in the differential diagnosis of ALT/WDLS by univariate analysis. […] FISH examination for MDM2 and CDK4 gene amplification has provided the most accuracy for the diagnosis of ALT/WDLS, and it is considered the gold standard for the differential diagnosis between ALT/WDLS and lipoma.
  • #2
    https://link.springer.com/article/10.1007/s11864-024-01262-9
    Myxoid liposarcoma (MLS) is a rare subtype of soft tissue sarcoma that distinguishes itself from conventional subtypes through its propensity for extrapulmonary metastasis. The distinctive magnetic resonance imaging (MRI) characteristics of MLS render it an invaluable tool for identifying primary and secondary lesions. […] Accurate diagnosis, facilitated by MRI and pathological assessment, is critical for prognostication and the formulation of appropriate treatment strategies. […] Surgery remains the cornerstone of local management for MLS. The combination of surgery and radiotherapy can significantly reduce the local recurrence rate in MLS, as it is highly sensitive to both radiotherapy and chemotherapy. […] Additionally, for high-risk MLS cases with a large tumor diameter, chemotherapy has been shown to improve survival.
  • #2 Myxoid Liposarcoma – Sarcoma Oncology Center
    https://sarcomaoncology.com/types-of-sarcoma/soft-tissue-sarcomas/liposarcoma/myxoid-liposarcoma/
    Many people with myxoid liposarcoma may not realize they have it because a lump might not appear until the tumor grows large enough to be noticeable. […] If the lump isnt causing pain, its easy to overlook. However, we advise you to see your doctor if you notice any new or unusual lumps. […] At Sarcoma Oncology Center, our oncologist may begin with a physical examination and ask about symptoms. We may suggest the following tests for the diagnosis of myxoid liposarcoma: […] If MLPS is suspected, we may ask for imaging tests like CT or MRI scans to determine the tumor’s size, location, and whether it has spread to other areas of the body. […] To confirm if the tumor is MLPS, you may need a biopsy. This involves using a needle to take a small tissue sample from the tumor. The sample is then examined under a microscope to identify the type of tumor and confirm the diagnosis. […] Myxoid liposarcoma requires a specialized approach for accurate diagnosis and effective treatment. At Sarcoma Oncology Center, our team of specialists provides comprehensive, evidence-based sarcoma care tailored to each case to ensure the best possible outcomes.
  • #2 Liposarcoma Diagnosis: Tests and Stages
    https://www.webmd.com/cancer/liposarcoma-testing-diagnosis
    A new or growing lump under your skin can be a symptom of liposarcoma, a type of cancer that starts in fat cells. […] If you do have liposarcoma, the earlier you get a diagnosis, the sooner you can start treatment. […] A biopsy is the only way to know for sure that you have liposarcoma. […] Your doctor will use the results of these tests to confirm whether you have liposarcoma and where it is in your body. They’ll give your cancer a grade and stage based on how different it looks from normal cells, how fast it grows, and whether it has spread. […] Based on the grade and stage of your cancer, your doctor will tell you what to expect and create a personalized treatment plan.
  • #2 Liposarcoma: A Journey into a Rare Tumor’s Epidemiology, Diagnosis, Pathophysiology, and Limitations of Current Therapies
    https://www.mdpi.com/2072-6694/16/22/3858
    Furthermore, the integration of histopathology, immunohistochemistry (IHC), and molecular testing is essential for accurate diagnosis and in guiding clinical management. […] Sarcomas are initially misdiagnosed in ~30% of cases, leading to delays in appropriate treatment. […] Ancillary diagnostic testing, such as IHC and molecular genetic testing, plays a crucial role in differentiating LS subtypes, particularly when histologic findings are inconclusive. […] Importantly, genomic profiling along with detailed histologic examination may help reduce misdiagnoses of LS subtypes. […] Following the initial diagnosis of LS, additional imaging can determine the extent of disease and any potential metastases.
  • #2 Liposarcoma: Types, Symptoms, Diagnosis, and Treatment – DoveMed
    https://www.dovemed.com/health-topics/focused-health-topics/liposarcoma-types-symptoms-diagnosis-and-treatment
    Liposarcoma is a rare type of cancer that develops in the soft tissues, specifically in the fat cells. […] To diagnose liposarcoma, healthcare professionals may use several methods, including: […] A biopsy involves the removal of a small tissue sample from the suspected tumor site for microscopic examination to confirm the presence of liposarcoma. […] Early detection and prompt treatment are crucial for the best possible outcomes. If you experience any concerning symptoms or notice unusual lumps or swelling, it is essential to consult with a healthcare professional for proper evaluation, diagnosis, and treatment.
  • #2
    https://link.springer.com/article/10.1007/s11864-024-01262-9
    The comprehensive treatment approach for MLS demonstrates superior local recurrence rates and survival rates compared to most soft tissue sarcomas. Current research focuses on developing effective therapies for unresectable or advanced disease based on genomic and phenotypic characteristics as well as the immune-tumor microenvironment.
  • #2 Myxoid liposarcoma – Overview of Information and Clinical Research
    https://clinicaltrials.eu/disease/myxoid-liposarcoma/
    Chemotherapy is another critical component of MLPS treatment, especially for larger tumors, advanced cases, or when the cancer has metastasized. […] Treatment for MLPS is highly individualized, taking into account the tumor’s characteristics, the patient’s overall health, and whether the cancer has spread. […] Early diagnosis plays a crucial role in improving the prognosis for myxoid liposarcoma. Detecting the cancer before it spreads allows for more effective treatment options and better outcomes. […] The prognosis for myxoid liposarcoma is generally better when the tumor is detected and treated before it spreads.